AstraZeneca PLC (AZN)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

12,926.00p

Buy

12,930.00p

arrow-down-424.00p (-3.18%)

Prices updated at 10 Jul 2026, 15:00 BST

Prices minimum 15 mins delay

Prices in GBX

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic ...

FTSE All-Share

0.3%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

	13,414.00p - 12,916.00p
	15,732.00p - 10,178.00p
	1.68
	207,104.11m
	26.55
	150
	1,052,131
	5.78
	2,328,464.95
	1.59
	1,550.91m
	GB0009895292
	6.64
	1.39

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.